POSTER SESSION II
Monday, March 9, 2009 — 1:00 PM - 4:30 PM
Hynes CC - Exhibit Hall C/D
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
GASTROINTESTINAL PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
63
The Value of Prospective Analysis of Mismatch Repair by Immunohistochemistry in Colorectal Cancer in the Irish Setting
(581)
R Geraghty, AA Maguire, D Kevans, D Keegan, J O'Sullivan, H Mulcahy, D O'Donoghue, J Hyland, D Winter, PR O'Connell, K Sheahan - St Vincent's University Hospital and Centre for Colorectal Disease, Dublin, Ireland
Immunohistochemical Detection of Sporadic and Hereditary Colorectal Carcinomas with Defective DNA Mismatch Repair
(580)
R Gafa, I Maestri, L Ulazzi, M Matteuzzi, G Lanza - Section of Anatomic Pathology, Ferrara, Italy
Multicentric Validation of a Model Based on Phenotypic Features To Predict Microsatellite Instability in Colorectal Adenocarcinomas
(660)
R Roman, M Verdu, A Vidal, M Calvo, X Sanjuan, M Jimeno, A Salas, J Autonell, I Trias, N Rodon, M Gonzalez, B Garcia, X Puig - BIOPAT. Biopatologia Molecular, Hospital de Barcelona, Histopat Laboratoris, Universitat de Barcelona, Hospital Universitari de Bellvitge, and Hospital del Mar, Barcelona, Spain; Hospital Mutua de Terrassa, Terrasa, Spain; Hospital General de Vic, Vic, Spain; Hospital Plato, Barcelona, Spain
Only Two Microsatellite Markers (Bat 26 and Bat 34c) Are Needed, with Immunohistochemistry, To Accurately Detect High Microsatelite Instability Cancers
(551)
J Beheshti, F Kuo, N Lindeman - Brigham and Women's Hospital, Boston, MA
Routine Mismatch Repair Protein Immunostaining in Colorectal Carcinomas - Equivocal MSH6 Staining Is a Challenge
(689)
MM Yearsley, AM Bellizzi, CD South, H Hampel, WL Marsh, WL Frankel - Ohio State University, Columbus, OH
Usefulness of p16 Immunohistochemistry in the Diagnosis of Lynch's Syndrome
(546)
C Alenda, A Paya, L Perez, E Alcaraz, JL Soto, C Guillen, V Barbera, A Carrato, A Castillejo, R Jover - University General Hospital, Alicante; University General Hospital, Elche AEG, Spain, Spain
Expression of Lgr5 in Colorectal Carcinoma Correlates with That of b -catenin: A Tissue Microarray Study
(574)
XS Fan, HP Yu, HY Wu, Q Zhou, Q Huang - Nanjing Drum Tower Hospital, Nanjing, China; Boston VA Healthcare System, Boston, MA
High Frequency of Loss of Heterozygosity in Colorectal Signet Ring Carcinomas Compared to Mucinous and Nonmucinous Adenocarcinomas
(624)
N Madiraju, G Deng, L Cun, YS Kim, S Kakar - UCSF and VA Medical Center, San Francisco, CA
High Frequency of E-Cadherin Methylation and Loss of Expression in Colorectal Signet Ring Cell Carcinoma Compared to Mucinous and Nonmucinous Adenocarcinoma
(665)
N Shafizadeh, G Deng, L Cun, YS Kim, S Kakar - University of California, San Francisco, San Francisco, CA; VA Medical Center, San Francisco, CA
Role of E-Cadherin and Beta-Catenin in Colorectal Cancer Progression
(614)
DT Leahy, M Milewski, E Fox, R Geraghty, H Mulcahy, J Hyland, D O'Donoghue, K Sheahan - University College Dublin, Centre for Colorectal Disease and St. Vincent's University Hospital, Dublin, Ireland
PIK3CA Mutation Predicts Poor Prognosis in Stage I-III Colorectal Cancer
(642)
S Ogino, K Nosho, GJ Kirkner, K Shima, N Irahara, S Kure, AT Chan, JA Engelman, P Kraft, LC Cantley, EL Giovannucci, CS Fuchs - Brigham and Women's Hospital, Harvard Medical School, Dana-Farber Cancer Institute, Harvard School of Public Heath, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center, Boston, MA
JC Virus T-Antigen Is Associated with p53 Expression, Chromosomal Instability and LINE-1 Hypomethylation in Colorectal Cancer
(638)
K Nosho, K Shima, S Kure, N Irahara, Y Baba, L Chen, GJ Kirkner, CS Fuchs, S Ogino - Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital, and Harvard School of Public Health, Boston, MA
LINE-1 Hypomethylation Is an Independent Predictor of Poor Prognosis in Colon Cancer
(641)
S Ogino, K Nosho, GJ Kirkner, T Kawasaki, AT Chan, ES Schernhammer, EL Giovannucci, CS Fuchs - Brigham and Women's Hospital, Harvard Medical School, Dana-Farber Cancer Institute, Harvard School of Public Health, Brigham and Women's Hospital, Massachusetts General Hospital, Boston, MA
Cyclin D1 Expression Marks a Subset of Colon Cancer with Good Prognosis
(643)
S Ogino, K Nosho, S Kure, N Irahara, K Shima, Y Baba, EL Giovannucci, CS Fuchs - Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, and Harvard School of Public Health, Boston, MA
Correlation of Expression of the Intestinal Biomarkers Guanylyl Cyclase C and CDX2 in a Large Cohort of Poorly Differentiated Colorectal Carcinomas
(687)
BJ Winn, R Tavares, L Noble, J Fanion, SA Waldman, MB Resnick - Rhode Island Hospital, The Warren Alpert Medical School of Brown University, Providence, RI; Thomas Jefferson University, Philadelphia, PA
Decrease in Expression of BRMS1 Correlates with the Tumor Progression and Metastatic Potential of Colorectal Adenocarcinoma
(654)
PA Phadke, H Ashby-Richardson, A S Barry, SP Naber, DR Welch - Tufts Medical Center, Boston, MA; University of Alabama at Birmingham, Birmingham, AL
Expression of Anti-Apoptotic Mcl-1 Protein Correlates with Higher Grade and Stage and Is a Marker of Metastasis in Colorectal Cancer
(593)
EB Henderson-Jackson, D Boulware, A Nasir, T Yeatman, D Coppola - H Lee Moffitt Cancer Center and Research Institute, Tampa, FL; University of South Florida College of Medicine, Tampa, FL
Nucleolin Expression in Colorectal Adenocarcinomas: Higher Nucleolin Expression Is Associated with Better Survival in Stage III Colorectal Cancers
(575)
X Fang, M Taggart, L Corley, H Wang, HM Wang, SR Hamilton, A Rashid - The University of Texas M.D. Anderson Cancer Center, Houston, TX
Loss of Nuclear PTEN Expression Is a Marker of Poor Prognosis in Stage II Colorectal Adenocarcinoma
¤600¥
KS Jang, YS Song, SH Jang, KW Min, W Na, SM Jang, YJ Jun, KH Lee, D Choi, SS Paik - College of Medicine, Hanyang University, Seoul, Republic of Korea; College of Medicine, Soon Chun Hyang University, Seoul, Republic of Korea
Leptin Expression Correlates with Favorable Clinicopathologic Phenotype and Better Prognosis in Colorectal Adenocarcinoma
(632)
W Na, SM Jang, KS Jang, KH Lee, DH Choi, SJ Jang, SS Paik - College of Medicine, Hanyang University, Seoul, Republic of Korea; Armed Forces Capital Hospital, Seongnam-si, Gyeonggi-do, Republic of Korea; College of Medicine, Soon Chun Hyang University, Seoul, Republic of Korea; Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea
Morphoproteomic Confirmation of an Activated NF-Kappa B Pathway in Colorectal Adenocarcinoma
(571)
S Dhingra, RE Brown, AL Cota, J Xiao, T Lei, X Duan - The University of Texas-Houston, Medical School, Houston, TX
UEV1A Is a Candidate Proto-Oncogene That Participates in NF- K B Activation
(674)
EE Torlakovic, L Pelzer, N Syed, K Lockheart, EC Marginean, B Davidson, W Xiao - College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada; Rikshospitalet-Radiumhospitalet Medical Center, University of Oslo, Oslo, Norway
Ten Year History of Colorectal Secondary Tumors: Hôpital St-Antoine, and Gustave-Roussy Institut Experience
(631)
N Mourra, C Shields, L Arrive, E Tiret, JF Flejou, P Duvillard - Hopital St-Antoine, Paris, France; Gustave-Roussy, Villejuif, France
Tumour Budding in TI and T2 Node-Negative (Dukes A) Colorectal Carcinoma
(568)
CA D'Arcy, D Kevans, AA Maguire, J O'Sullivan, H Mulcahy, D O'Donoghue, J Hyland, D Winter, PR O'Connell, K Sheahan - St Vincent's University Hospital and Centre for Colorectal Disease, Dublin, Ireland
Ampullary Biopsies: Morphological Features and Useful Biomarker Panel of Adenocarcinoma and Adenoma - A Single Institutional Experience on 273 Ampullary Biopsies
(558)
W Cao, J Liao, MS Rao, G Yang - Northwestern University, Chicago, IL
Ampulla of Vater: Morphologic, Clinical, Survival, and Second Colon Primary Cancers Based on 5,625 Cases from the SEER Program
(545)
J Albores-Saavedra, K Batich, AM Schwartz, DE Henson - Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, Mexico; George Washington University Cancer Institute, and George Washington University Medical Center, Washington, DC
Hilar Cholangiocarcinoma: A Comparison of Endoscopic Transpapillary Brush Cytology an Forceps Biopsy
(590)
CH von Weyhern, A Weber, J Schneider, B Neu, A Meining, H Weidenbach, RM Schmid, F Fend, C Prinz - University Hospital Tuebingen, Tuebingen, Germany; University Hospital Technical University, Munich, Germany
Adenocarcinoma of the Small Intestine: A Multi-Institutional Study of 197 Cases
(595)
S-M Hong, E Yu, JH Kim, YK Bae, K-T Jang, H-K Chang, ES Jung, G-S Yoon, H-I Bae, JM Kim, Y-H Oh, GI Kim, SJ Jung, MJ Gu, JY Kim, KY Jang, S-Y Jun, DW Eom, KW Kwon, GH Kang, JB Park, SW Hong, JS Lee - Johns Hopkins Medical Institutions, Baltimore, MD; Korean Small Intestinal Cancer Study Group, Seoul, Korea
Analysis of Incidence and Expression Levels of a Cancer-Specific CCK2 Receptor Splice Variant in Gastrointestinal and Lung Tumors
(610)
M Korner, B Waser, JC Reubi, LJ Miller - Mayo Clinic, Scottsdale, AZ; Institute of Pathology of the University of Berne, Berne, Switzerland
Expression of Cadherin 17 in the Gastrointestinal Tract, Liver and Pancreas: Comparison with CDX2 as a Diagnostic Marker
(646)
NC Panarelli, RK Yantiss, Y-T Chen - Weill Cornell Medical College, New York, NY
Frequent Overexpression of HMGA1 and HMGA2 in Gastroenteropancreatic Neuroendocrine Tumors and Its Relationship to Let-7 Down-Regulation
(657)
ZR Qian, MM Rahman, EL Wang, R Sultana, E Kudo, M Nakasono, T Hayashi, T Sano - Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima, Japan; Faculty of Medicine, Kagawa University, Takamatu, Kagawa, Japan
CDKN2 and MTAP Deletions in Peritoneal Mesotheliomas: Correlation with Loss of p16 Protein Expression and Survival
(611)
AM Krasinskas, D Bartlett, K Cieply, S Dacic - University of Pittsburgh, Pittsburgh, PA
button next to any title to add to Itinerary Planner...
Add
